Alfacell Corp (NASDAQOTH:ACEL.PK)
CAPS Rating:
A biopharmaceutical company, primarily engaged in the discovery and development of a new therapeutic class of drugs for the treatment of cancer and other pathological conditions.
RSS Headlines
Fool UK
Recs
Greatest untold story in biotech. Will most likely be first RNAi product to market with many other applications to follow. Look towards anti-viral and cancer prophylactic.